Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R21AR073380-01, 1R21AR078976-01, 1R01AR077238-01A1)
Article History
Received: 17 August 2022
Accepted: 14 December 2022
First Online: 23 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: TA is a consultant for Stemson Therapeutics, LLC. All other authors declare no competing interests.